Atlas Capital Advisors’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-859
Closed -$9.42K 677
2019
Q3
$9.42K Hold
859
﹤0.01% 576
2019
Q2
$26.4K Hold
859
0.01% 535
2019
Q1
$36K Hold
859
0.01% 442
2018
Q4
$39.1K Hold
859
0.02% 433
2018
Q3
$70.8K Hold
859
0.02% 395
2018
Q2
$92.3K Buy
+859
New +$92.3K 0.03% 348